Figure 4: Horizontal spectral domain optical coherence tomography image through the fovea of the right eye one month after Ranibizumab therapy shows reduction of the central foveal thickness and complete resolution of the cystoid changes. Few hyperreflective dots corresponding to hard exudates are still seen and central loss of ellipsoid zone is seen centrally (between open arrows).